Product Information

TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP is a generic product labeled by Viona Pharmaceuticals Inc., priced at $0.1205 per EA under NDC 72578009010. Its NADAC has been published 273 times since Apr 7, 2021.

TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP

Triamterene and Hydrochlorothiazide
$0.1205per EA

Strength

25; 37.5 mg/1; mg/1

NDC

72578009010

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA208358

On Market Since

2/21/2020

Pharmacological Classes

Decreased Renal K+ Excretion
Increased Diuresis
Increased Diuresis
Potassium-sparing Diuretic
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP has been published 273 times since Apr 7, 2021, and over the history we have for it it has declined 20.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1205 per EA
All-time high$0.1577 (May 12, 2021)
All-time low$0.0844 (Jul 17, 2024)
52-week high$0.1205
52-week low$0.1128
Median price$0.1261
Average price$0.1263
Largest weekly change+46.0% (Aug 21, 2024)
Weeks tracked273
Tracking sinceApr 7, 2021

Price History

1W

0.0%

1M

+1.3%

3M

+5.0%

6M

+2.0%

1Y

+5.6%

3Y

+2.7%

5Y

-19.1%

All

-20.1%

Generic Alternatives

The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 20% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP?

The current National Average Drug Acquisition Cost (NADAC) for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP, manufactured by Viona Pharmaceuticals Inc., is $0.1205 per EA (NDC 72578009010), effective Jun 24, 2026.

How has the price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP changed over time?

Over the history we have for it, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP has declined 20.1%. It has been tracked across 273 weekly CMS publications since Apr 7, 2021.

What are the highest and lowest recorded NADAC prices for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP?

Since Apr 7, 2021, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP has ranged from a low of $0.0844 (Jul 17, 2024) to a high of $0.1577 (May 12, 2021), with a median of $0.1261 per EA.

Are there cheaper alternatives to TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP?

Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB, is $0.0960 per EA — about 20% below TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP.

Who manufactures TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP?

TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP (NDC 72578009010) is labeled by Viona Pharmaceuticals Inc., and CMS classifies it as a generic product.